Other languages Biocon Limited

Equities

BIOCON

INE376G01013

Delayed NSE India S.E. Other stock markets 06:29:28 2024-05-02 am EDT			5-day change	1st Jan Change
310.9 ^INR	+4.14%		+10.98%	+24.53%

Apr. 30	Natural Biocon (India) CFO Passes Away	MT
Apr. 20	Biocon Limited Receives Approval from the South African Health Products Regulatory Authority for its Vertically Integrated, Complex Drug Product Tacrolimus Capsule 0.5mg, 1mg and 5mg Strengths, in South Africa	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biocon Limited Receives Approval from the South African Health Products Regulatory Authority for its Vertically Integrated, Complex Drug Product Tacrolimus Capsule 0.5mg, 1mg and 5mg Strengths, in South Africa	Apr. 20
India's Biocon developing its own version of Wegovy, clinical trial likely next year	Apr. 18
Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A	Apr. 17
Biocon Board to Consider Dividend for Fiscal 2024	Apr. 10
Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business	Apr. 02
Biocon Limited, Through Zentiva, Receives Approval from, U.K., for its Complex Formulation Liraglutide (gSaxenda®) in 6mg/ml Solution	Mar. 31
Biocon Limited to Obtain Approval for Diabetes Drug, Liraglutide, in the U.K	Mar. 27
Eris Lifesciences to Acquire India Formulation Business of Biocon Biologics for INR12.42 Billion	Mar. 15
Biocon's CFO Resigns	Mar. 14
Eris to Acquire Additional Stake in Swiss Parenterals, Take Over Branded Formulations Business of Biocon Biologics	Mar. 14
India's Biocon to sell branded formulations business to Eris Lifesciences for $150 million	Mar. 14
Biocon Limited Announces Executive Appointments	Mar. 04
Biocon Arm to Launch Colorectal Cancer Biosimilar in Canada	Mar. 04
Bristol Myers CEO says India to have largest R&D presence outside US by 2025	Feb. 27
INDIA STOCKS-Indian shares muted after five-session rally, tracking Asian peers	Feb. 19
Biocon Swings to Profit in Fiscal Q3	Feb. 09
Indian shares set for a muted start, tracking Asian peers	Feb. 08
Biocon CFO Resigns	Feb. 08
India's Biocon posts profit on biosimilar boost, divestment gains; CFO resigns	Feb. 08
Biocon Limited Announces Nehal Vora Resigns as Commercial Head, Effective March 31, 2024	Feb. 08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biocon Limited

Equities

BIOCON

INE376G01013

Other languages

Filters